Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Axonics Inc (AXNX)

Axonics Inc (AXNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Axonics: Q1 Earnings Snapshot AP - Tue Apr 30, 3:08PM CDT

Axonics: Q1 Earnings Snapshot

AXNX : 67.72 (-0.41%)
Axonics: Q4 Earnings Snapshot AP - Wed Feb 28, 3:41PM CST

Axonics: Q4 Earnings Snapshot

AXNX : 67.72 (-0.41%)
Why Axonics Stock Soared Today Motley Fool - Mon Jan 8, 6:38PM CST

The medical device maker agreed to be acquired by Boston Scientific.

AXNX : 67.72 (-0.41%)
BSX : 77.56 (+2.66%)
Axonics: Q3 Earnings Snapshot AP - Mon Oct 30, 2023

Axonics: Q3 Earnings Snapshot

AXNX : 67.72 (-0.41%)
Why Shares of Axonics Rose Friday Motley Fool - Fri Jul 28, 2023

The company showed improved revenue and margins in its second-quarter report.

MDT : 79.48 (-2.13%)
AXNX : 67.72 (-0.41%)
Axonics: Q2 Earnings Snapshot AP - Thu Jul 27, 2023

Axonics: Q2 Earnings Snapshot

AXNX : 67.72 (-0.41%)
Axonics: Q1 Earnings Snapshot AP - Mon May 1, 2023

Axonics: Q1 Earnings Snapshot

AXNX : 67.72 (-0.41%)
Axonics Reports First Quarter 2023 Financial Results Business Wire - Mon May 1, 2023

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results...

AXNX : 67.72 (-0.41%)
Axonics to Participate in Upcoming Investor Conferences Business Wire - Tue Apr 25, 2023

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in...

AXNX : 67.72 (-0.41%)
Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation Business Wire - Mon Apr 24, 2023

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the acquisition...

AXNX : 67.72 (-0.41%)

Barchart Exclusives

3 'Strong Buy' Small-Caps With 27% to 146% Upside Potential Barchart - 9 minutes ago
This article highlights three small-cap stocks with 'Strong Buy' ratings that offer substantial upside potential of 27% to 146% and are poised to benefit from current market trends. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot